500 lung cancer patients to help map asian genetic subtypes

NCT ID NCT04025515

Terminated Knowledge-focused Sponsor: National Cancer Centre, Singapore Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study collects and analyzes lung cancer tissue samples from 500 patients in Asia to find out which genetic changes are most common. The goal is to better understand the disease in the local population. Participants must have a tissue sample available and be healthy enough for potential future trials, but no new treatment is given as part of this study.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

lung cancer lung neoplasm non-small cell lung carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LUNG CANCER NON-SMALL CELL LUNG CANCER

Contacts and locations

Locations

Beacon Hospital

Petaling Jaya, Malaysia
Hong Kong Integrated Oncology Centre

Hong Kong, Hong Kong
National Cancer Centre Singapore

Singapore, Singapore
Pantai Hospital, Kuala Lumpur

Kuala Lumpur, Malaysia
Penang Adventist Hospital

George Town, Malaysia
Phramongkutklao Hospital

Bangkok, Thailand
Rajiv Ghandhi Cancer Institute and Research Centre

New Delhi, India
The Brunei Cancer Centre

Brunei, Brunei
The Chinese University of Hong Kong, Department of Clinical Oncology

Hong Kong, Hong Kong
University Malaya Medical Centre, Clinical Oncology Department

Kuala Lumpur, Malaysia

More trials for these conditions

Other studies related to the condition(s) this trial covers.